Korge, Paavo, Joshua I. Goldhaber, and James N. Weiss. Phenylarsine oxide induces mitochondrial permeability transition, hypercontracture, and cardiac cell death. Am J Physiol Heart Circ Physiol 280: H2203-H2213, 2001.-The mitochondrial permeability transition (MPT) is implicated in cardiac reperfusion/reoxygenation injury. In isolated ventricular myocytes, the sulfhydryl (SH) group modifier and MPT inducer phenylarsine oxide (PAO) caused MPT, severe hypercontracture, and irreversible membrane injury associated with increased cytoplasmic free [Ca 2ϩ ]. Removal of extracellular Ca 2ϩ or depletion of nonmitochondrial Ca 2ϩ pools did not prevent these effects, whereas the MPT inhibitor cyclosporin A was partially protective and the SH-reducing agent dithiothreitol fully protective. In permeabilized myocytes, PAO caused hypercontracture at much lower free [Ca 2ϩ ] than in its absence. Thus PAO induced hypercontracture by both increasing myofibrillar Ca 2ϩ sensitivity and promoting mitochondrial Ca 2ϩ efflux during MPT. Hypercontracture did not directly cause irreversible membrane injury because lactate dehydrogenase (LDH) release was not prevented by abolishing hypercontracture with 2,3-butanedione monoxime. However, loading myocytes with the membrane-permeable Ca 2ϩ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid-acetoxymethyl ester (BAPTA-AM) prevented PAO-induced LDH release, thus implicating the PAO-induced rise in cytoplasmic [Ca 2ϩ ] as obligatory for irreversible membrane injury. In conclusion, PAO induces MPT and enhanced susceptibility to hypercontracture in isolated cardiac myocytes, both key features also implicated in cardiac reperfusion and reoxygenation injury. injury is closely connected with the mitochondrial permeability transition (MPT), as Crompton and co-workers suggested in the late 1980s (see Refs. 5, 17, and 24 for reviews). MPT is caused by the opening of permeability transition pores (PTP) in the inner mitochondrial membrane, causing collapse of membrane potential, mitochondrial Ca 2ϩ efflux, equilibration of solutes with molecular mass Ͻ1,500 Da across the inner membrane, and the inability of the mitochondria to generate ATP (5). Available experimental evidence suggests that PTP remain closed during ischemia but open during reperfusion (15). Hypercontracture is another hallmark of reperfusion/reoxygenation in cardiac muscle that exacerbates injury by disrupting membrane integrity. Hypercontracture requires both elevated intracellular [Ca 2ϩ ] and ATP availability for cross-bridge cycling (see Ref. 30 for a review). However, relative to the elevated levels of cytoplasmic [Ca 2ϩ ] during ischemia/ hypoxia, the lack of a further large increase in cytoplasmic [Ca 2ϩ ] on reperfusion/reoxygenation (16, 26) suggests that reperfusion/reoxygenation increases the susceptibility of cardiomyocytes to hypercontracture (30). This is supported by the observation that cells develop Ca 2ϩ -induced hypercontracture at significantly lower cytosolic Ca 2ϩ levels after hypoxia/reoxygenation than during normoxia (23).
injury is closely connected with the mitochondrial permeability transition (MPT), as Crompton and co-workers suggested in the late 1980s (see Refs. 5, 17, and 24 for reviews). MPT is caused by the opening of permeability transition pores (PTP) in the inner mitochondrial membrane, causing collapse of membrane potential, mitochondrial Ca 2ϩ efflux, equilibration of solutes with molecular mass Ͻ1,500 Da across the inner membrane, and the inability of the mitochondria to generate ATP (5) . Available experimental evidence suggests that PTP remain closed during ischemia but open during reperfusion (15) . Hypercontracture is another hallmark of reperfusion/reoxygenation in cardiac muscle that exacerbates injury by disrupting membrane integrity. Hypercontracture requires both elevated intracellular [Ca 2ϩ ] and ATP availability for cross-bridge cycling (see Ref. 30 for a review). However, relative to the elevated levels of cytoplasmic [Ca 2ϩ ] during ischemia/ hypoxia, the lack of a further large increase in cytoplasmic [Ca 2ϩ ] on reperfusion/reoxygenation (16, 26) suggests that reperfusion/reoxygenation increases the susceptibility of cardiomyocytes to hypercontracture (30) . This is supported by the observation that cells develop Ca 2ϩ -induced hypercontracture at significantly lower cytosolic Ca 2ϩ levels after hypoxia/reoxygenation than during normoxia (23) .
The hydrophobic sulfhydryl group reagent phenylarsine oxide (PAO), which specifically cross-links vicinal sulfhydryl groups (36) , has been found to be a potent inducer of MPT in isolated mitochondria (2) . To further investigate the role of mitochondrial permeability transition (MPT) in cardiac injury, we examined the effects of PAO in isolated ventricular myocytes. We show that PAO induces MPT and causes both severe hypercontracture and irreversible membrane injury. The mechanisms underlying these effects are explored.
MATERIALS AND METHODS

Isolated Ventricular Myocyte Studies
Isolation procedure. Myocytes were isolated from adult rabbit hearts by the conventional enzymatic method described previously (25a) . Cells were stored in normal Tyrode solution and used within 5-6 h.
Confocal microscopy. Single myocytes loaded with fluorescent probe(s) were imaged with an Odyssey XL laser-scanning confocal microscopy system (Noran Instruments; Middleton, WI) attached to a Ziess Axiovert TV100 fitted with a ϫ40 water immersion objective lens (model 40/1.2 W Corr; Apochromat). Tetramethyl rhodamine methyl ester (TMRM) and rhodamine 2 (rhod 2) were loaded at room temperature and calcein was loaded as described below. The red fluorescence of TMRM and rhod 2 were excited with the use of the 568-nm line of an argon laser, and emission was collected above 590 nm through a long-pass filter. Calcein fluorescence was excited at 488 nm and imaged through a 515-nm band-pass filter.
Selective loading of calcein into mitochondria. In isolated myocytes, MPT was evaluated by selectively loading mitochondria with the fluorescent dye calcein (molecular mass 623 Da). We modified the method developed recently by Petronilli et al. (29) , who used mitochondrial calcein efflux to detect MPT in liver cells by quenching cytosolic and nuclear calcein fluorescence with Co 2ϩ . Once inside the mitochondrial matrix, calcein is trapped unless MPT occurs and allows calcein to efflux through PTP (molecular mass cutoff ϳ1,500 Da in the high-conductance mode of MPT). MPT is therefore detected in the confocal image of the myocyte when the discrete striped mitochondrial pattern of calcein fluoresence is lost and replaced by a diffuse fluorescence pattern.
To selectively load mitochondria with calcein, myocytes were incubated in Tyrode buffer containing 10 M calceinacetoxymethyl ester (AM) for 60 min at 4°C. After 60 min, cells were allowed to sediment at the bottom of the test tube at 4°C, the buffer was removed, and cells were resuspended in buffer without calcein. The cells were then incubated at 37°C for 3-4 h, during which time the buffer was changed three to four times. This incubation was necessary to selectively visualize the calcein fluorescence originating from mitochondria, leading us to hypothesize that during the warm incubation, calcein leaked out from the cytoplasm but was retained in mitochondria. Preferential loss of cytoplasmic compared with mitochondrial fluorophores during warm incubation of myocytes has been noted by others (35) . The efficiency of cytoplasmic calcein removal was tested by periodically examining a sample of myocytes under the confocal microscope during warm incubation.
Preferential mitochondrial distribution of calcein was confirmed by its colocalization with TMRM ( Fig. 1) . Isolated myocytes were first loaded with calcein as described and imaged under the confocal microscope (Fig. 1A) . TMRM (100 nm) was then added, and the same cell was imaged for the red fluorescence of TMRM (Fig. 1B) . Dual fluorescence images obtained at 515 nm (for calcein) and at Ͼ590 nm (for TMRM) demonstrated nearly identical patterns. Mitochondrial localization of calcein was also supported by its fluorescence colocalization with another mitochondrial-specific probe, MitoTracker Green (data not shown). Compared with the method of Petronelli et al. (29) ] was calculated with the use of Winmax version 2.05 software. Cell length was recorded by using a video edge detector, as described previously (37) .
Isolated Mitochondria Studies
Isolation of mitochondria. Mitochondria were isolated from adult rabbit hearts by enzymatic digestion of finely minced tissue with the bacterial protease nagarase (0.5 mg/ml) for 10 min on ice in a homogenization buffer composed of (in mM) 250 sucrose, 1 EGTA, and 10 3-(N-morpholino)propanesulfonic acid (pH 7.4 with Tris) and differential centrifugation, as described previously (22) . Mitochondria were resuspended in the EGTA-free homogenization buffer to give ϳ40 mg/ml of mitochondrial protein, kept on ice, and used within 6 h after isolation. The respiratory control ratio, determined in mitochondrial incubation buffer composed of (in mM) 120 KCl, 10 HEPES (pH 7.4), and 2 potassium phosphate to which 2.5 mM of pyruvate, malate, and glutamate and 0.5 mM of ADP were consecutively added, was Ͼ5, suggesting that isolated mitochondria were well coupled.
Evaluation of mitochondrial matrix swelling and membrane potential. The rate of change of mitochondrial matrix volume was estimated by measuring 90°light scattering with the use of a spectrofluorometer with excitation and emission wavelengths set at 520 nm, similar to the method described by Haworth and Hunter (18) to measure MPT by mitochondrial matrix volume changes. The membrane potential (⌬⌿) was measured in parallel with matrix volume changes by transmembrane distribution of TMRM. Mitochondria (0.5-1.0 mg) were added to 2 ml of mitochondrial incubation buffer containing 400 nM TMRM, and continuously stirred, and the effect of PAO alone or in combination with other chemicals on light scattering or TMRM fluorescence emission (580 nm) was recorded.
Mitochondrial Ca 2ϩ uptake and efflux determination. Mitochondria (0.5-1 mg/ml) were incubated in the buffer described above containing 1 M Ca 2ϩ green 5N. The suspension was continuously stirred in the fluorometer cuvette, and changes in extramitochondrial [Ca 2ϩ ] were followed by recording Ca 2ϩ green fluorescence as described above for fluo 3. Calibration of the signal was achieved by the addition of known amounts of Ca 2ϩ to incubation buffer as described previously (21) except that the buffer also contained 1 mg/ml of bovine serum albumin.
Myosin ATPase Activity
Actin-activated heavy meromyosin (HMM) ATPase activity was determined by measuring the rate of nicotinamide adenine dinucleotide (NADH) oxidation, proportional to the rate of ADP production, in a buffer containing 1 mM MgCl2, 0.5 mM EGTA, 10 mM phosphoenolpyruvate, 10 U/ml pyruvate kinase, 15 U/ml lactate dehydrogenase (LDH), 0.5 mM NADH, and 10 mM HEPES; pH 7.4 at 25°C. HMM and F-actin (10 M) were added first, followed by ATP. In control experiments, PAO had no effect on enzymes used to determine ATPase activity.
LDH Release
Cells were allowed to sediment on Falcon dishes, and the supernatant was changed with the fresh buffer several times. The cells, which were loosely attached to the bottom, were incubated at room temperature with or without PAO and other additions, and 150 l of supernatant was carefully removed after the indicated time periods for LDH determination. LDH activity was determined by oxidation of NADH in potassium phosphate buffer, pH 7.65, containing 1 mM of sodium pyruvate. LDH release during metabolic inhibition was evaluated relative to the total cellular LDH content (31) .
All of the experiments were conducted at room temperature (23-25°C). All of the tracings or fluorescence images are representative of experiments from at least three different isolated myocyte preparations. When appropriate, original tracings were analyzed and the results presented as means Ϯ SD.
Chemicals
Cyclosporin A (CSA) was a gift from Ciba-Geigy. HMM and actin, isolated from the rabbit heart, were gifts from Dr. E. Homsher. Percoll was purchased from Pharmacia, and all of the fluorescent dyes were purchased from Molecular Probes. All of the other chemicals were purchased from Sigma.
RESULTS
PAO Induces MPT and Hypercontracture in Isolated Ventricular Myocytes
To image MPT in intact isolated myocytes, mitochondria inside myocytes were selectively loaded with calcein (see MATERIALS AND METHODS) and imaged with confocal microscopy before and during exposure to PAO. PAO (20 M) caused the striped pattern typical of intramitochondrial localization of calcein to be progressively replaced by a more diffuse fluorescence, indicating calcein efflux from mitochondria to cytoplasm as MPT occurred ( Fig. 2 ; n ϭ 5). Coincident with the diffuse fluorescence pattern, the myocyte underwent progressive shortening leading to hypercontracture. The effects of PAO were dose dependent (10-50 M), and at 20 M typically began after a lag period of 2-4 min (n ϭ 5). Once shortening began, the myocyte changed from a rod shape to a rounded shape within 2-3 min (see Fig. 2 ), and its surface became covered with membrane blebs.
Pretreating myocytes with the cross-bridge uncoupler 2,3-butanedione monoxime (BDM; 30 mM) (33) prevented cell shortening during PAO exposure yet did not prevent the loss of the striped fluorescence pattern, although it developed more slowly (n ϭ 3; Fig. 2 ). Thus the change in calcein fluorescence pattern was not an artifact of severe cell shortening.
PAO-Induced Hypercontracture Requires Intracellular Ca 2ϩ and ATP
In isolated myocytes loaded with fluo 3-AM or rhod 2-AM, PAO caused a modest increase in cytosolic Ca 2ϩ over a similar time course as hypercontracture (Fig. 3 , A and B, confirmed in five cell suspensions). When extracellular Ca 2ϩ was replaced with EGTA, hypercontracture still developed, albeit at a modestly slower rate (Fig. 4, A and B) . However, preloading myocytes with 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid-AM (BAPTA-AM; a membrane-permeable, highly specific Ca 2ϩ -chelating reagent) completely prevented hypercontracture (Fig. 4A, trace c) . Figure 5A shows that the sulfhydryl-reducing agent dithiothreitol (DTT) reversed the effects of PAO when applied within a few minutes of the onset of hypercontracture. These traces also show that neither the elimination of Na/Ca exchange nor the sarcoplasmic reticulum function had significant effects on PAO-induced hypercontracture. The time to 50% hypercontracture for those groups is shown in Fig. 5B . Only preincubation with BAPTA-AM prevented hypercontracture (see Figs. 4 and 6), substantiating the requirement for intracellular Ca 2ϩ in PAO-induced hypercontracture (also confirmed in permeabilized cells, as shown later). Inhibiting other Ca 2ϩ transport mechanisms likewise did not affect the ability of DTT to reverse PAO-induced hypercontracture (Fig. 5A) , suggesting that the relaxant effect of DTT was mediated by another mechanism besides reducing cytoplasmic [Ca 2ϩ ] (see below). These findings eliminate extracellular Ca 2ϩ influx and sarcoplasmic reticulum Ca 2ϩ release as primary causes of the PAO-induced rise in cytoplasmic Ca 2ϩ . Because PAO has been shown to increase intracellar [Ca 2ϩ ] in endothelial cells in association with tyrosine phosphorylation of cytoskeletal proteins (11), we also examined the effect of peroxyvanadate (0.1 mM), a potent tyrosine phosphatase inhibitor, but it failed to induce hypercontracture over 30 min (data not shown). By exclusion, these results suggest that mitochondrial Ca 2ϩ efflux by PAO is sufficient to raise cytoplasmic free [Ca 2ϩ ] to a level causing hypercontracture. PAOinduced hypercontracture did not depend on mitochondria being highly Ca 2ϩ loaded, because pretreatment with the mitochondrial Ca 2ϩ uniporter inhibitor ruthenium red (2 M) did not change the time to 50% hypercontracture in response to PAO (Fig. 5B) . Even with all of these interventions (except BAPTA loading), PAO still led to hypercontracture within the same time frame (Fig. 5B) . The reason why such a modest increase in cytoplasmic free Ca 2ϩ caused hypercontracture in the presence of PAO is addressed later.
Hypercontracture was not equivalent to rigor, because severe ATP depletion with carbonyl cyanide ptrifluoromethoxyphenylhydrazone (FCCP) caused cell shortening only to a brick, rigor form (to ϳ50-70% initial cell length), without progressing further to rounded shapes (to Ͻ30% initial cell length) as in Fig.  2 . FCCP, which causes fast Ca 2ϩ efflux from mitochondria via the uniporter (28), also caused cytoplasmic free [Ca 2ϩ ] to increase, albeit to lesser extent than PAO (Fig. 3B) . In contrast, ATP depletion was much more rapid with FCCP than PAO (Fig. 3C) . In fact, if cellular ATP levels were depressed drastically by FCCP before exposure to PAO, PAO no longer induced hypercontracture (n ϭ 10; Fig. 6 ). If ATP depletion by FCCP was slowed with oligomycin, which prevents F 0 F 1 -ATPase from consuming ATP when the mitochondrial proton gradient is dissipated (25) , the ability of PAO to induce hypercontracture was restored (n ϭ 6; Fig. 6 ).
The MPT inhbitor CSA (0.4 M) was only partially effective at preventing PAO-induced hypercontracture (n ϭ 8; Fig. 6 ), but DTT and N-ethylmaleimide (NEM) were completely effective (n ϭ 12 and 5, respectively; Fig. 6 ). These compounds prevent cross-linking by reducing or modifying sulfhydryl groups, confirming that the effects of PAO were selectively mediated by crosslinking of vicinal sulfhydryl groups. In isolated cardiac mitochondria, PAO-induced MPT was also reversed by DTT, provided substrate was present to allow ⌬⌿ recovery (n ϭ 4 preparations; Fig. 7A ). The rapid time course of DTT-induced ⌬⌿ recovery in isolated mitochondria was comparable to the rapid reversal of PAOinduced hypercontracture by DTT in intact myocytes (Fig. 5A) . In contrast, renormalization of cytoplasmic ATP levels after ⌬⌿ recovery occurs over a time course of many minutes (8), making it unlikely that an increased ATP-to-ADP ratio (17) was responsible for the rapid reversal of hypercontracture by DTT. This suggests that PAO may have a direct effect on myofilament Ca 2ϩ sensitivity, which can be rapidly reversed by DTT. This possibility was further tested in permeabilized cardiac myocytes, as described below.
PAO Increases Myocyte Susceptibility to Hypercontracture by Increasing Myofibrilar Ca 2ϩ Sensitivity
To examine the effects of PAO on susceptibility to Ca 2ϩ -induced hypercontracture, we permeabilized the sarcolemma of isolated myocytes with digitonin (20 M). In the presence of 3 mM ATP and 0.5 mM EGTA, permeabilized myocytes retained a rod-shape morphology and typically tolerated additions of Ca 2ϩ until the buffered free [Ca 2ϩ ] in the bath reached Ͼ10 M, at which point they rapidly underwent hypercontracture (Fig. 8A) . PAO, at 50 M, had no effect on cell length in the absence of Ca 2ϩ , confirming a Ca 2ϩ requirement for 8B ). Thus PAO increased myofilament sensitivity to Ca 2ϩ . Although we cannot exclude the possibility that this effect was mediated by MPT-related alterations in local myofibrillar ATP-to-ADP ratios, a well-recognized determinant of the myofibrillar Ca 2ϩ sensitivity (17), the rapid reversal by DTT, suggests that cross-linking of vicinal sulfhydryl groups of the contractile elements may be involved. We examined whether PAO affected myofibrillar ATP hydrolysis, but 50 M PAO had no effect on actin-activated HMM activity ( Fig. 8C; n ϭ 3) .
PAO-Induced Mitochondrial Ca 2ϩ Release
The above results indicate that both increased myofilament Ca 2ϩ sensitivity and a modest increase in cytoplasmic free [Ca 2ϩ ] are required for PAO to induce hypercontracture. Furthermore, Fig. 5 demonstrates that even when extracellular Ca 2ϩ was removed and sarcoplasmic reticulum Ca 2ϩ was depleted from resting aerobically superfused myocytes, their mitochondria retained sufficient releasable Ca 2ϩ to induce hypercontracture in response to PAO. To examine whether PAO could elevate extramitochondrial Ca 2ϩ to a significant extent in non-Ca 2ϩ -loaded mitochondria, heart mitochondria were isolated and incubated in KCl buffer, which contains several micromolars of contaminant Ca 2ϩ . In this setting, nonenergized mitochondria were not expected to accumulate a significant amount of contaminant Ca 2ϩ , but some accumulation cannot be excluded. The addition of PAO-induced ⌬⌿ depolarization and rapid matrix swelling indicates MPT and concomitantly produced a significant rise in extramitochondrial [Ca 2ϩ ] due to Ca 2ϩ efflux (Fig. 9A) . Although we did not measure matrix free [Ca 2ϩ ], experiments under comparable conditions in beef heart mitochondria in KCl-HEPES-low-Ca 2ϩ buffer determined this value to be 0.25 M, similar to the values (0.1-0.2 M) reported for mitochondrial matrix free [Ca 2ϩ ] in resting isolated myocytes (6, 26) . Paradoxically, this is equivalent to the resting cytoplasmic free [Ca 2ϩ ] in isolated cardiac myocytes. Therefore, to generate a driving force for Ca 2ϩ efflux, PAO would have to release Ca 2ϩ from matrix buffering sites [the estimated matrix total-to-free Ca 2ϩ ratio is ϳ6,000 under physiological conditions (20) , similar to the effects of intracellular acidosis (12)].
To test this possibility, we permeabilized isolated mitochondria with alamethicin (Fig. 9B) . Control experiments using TMRM showed that alamethicin completely dissipated ⌬⌿ (n ϭ 6 preparations), similar to PAO Figure 10A shows that PAO led to irreversible membrane injury, as judged by cellular LDH release. Similar to hypercontracture, PAO-induced LDH release did not require extracellular [Ca 2ϩ ] (Fig. 10A) . However, the time course of LDH release was much slower than hypercontracture, suggesting that irreversible membrane injury was not mediated mechanically. In addition, BDM totally prevented hypercontracture yet did not prevent PAO-induced LDH release (Fig. 10B ). Adding CSA with BDM to the incubation medium before PAO exposure markedly inhibited LDH release (Fig. 10B) , suggesting that sarcolemmal membrane damage was directly related to MPT. CSA also decreased LDH release without BDM but was less effective. Coupled with the observation that BATPA prevented hypercontracture (Fig. 6 ) and LDH release (Fig.  10B) , these findings implicate the rise in intracellular Ca 2ϩ during MPT as a primary cause of sarcolemmal membrane injury in isolated myocytes, with hypercontracture playing at most a secondary role.
PAO Causes Irreversible Sarcolemmal Damage and Cell Death
DISCUSSION
This study shows that, in isolated cardiac myocytes, the chemical MPT inducer PAO caused severe hypercontracture and irreversible sarcolemmal injury. PAO increased myofibrillar Ca 2ϩ sensitivity, explaining why hypercontracture occurred with only a modest increase in cytoplasmic free [Ca 2ϩ ] associated with MPT-induced mitochondrial Ca 2ϩ efflux. Irreversible membrane injury, attributed to MPT-induced changes in cytoplasmic [Ca 2ϩ ] and [ATP], developed independently of hypercontracture. PAO had no effect on actin-activated heavy meromyosin ATPase activity. At the top arrow 1 or 5 M ATP was added, followed by 50 M PAO at the bottom arrow. This experiment was repeated three times with equivalent results. Contr, control.
PAO-Induced Hypercontracture
In isolated cardiac myocytes, PAO was very effective at inducing MPT (see Fig. 2 ) but also markedly increased susceptibility to hypercontracture at cytoplasmic free [Ca 2ϩ ] normally well tolerated by permeabilized myocytes (see Fig. 8 ). In this setting, mitochondrial Ca 2ϩ efflux due to PAO-induced MPT provided sufficient [Ca 2ϩ ] to induce hypercontracture, because removal of extracellular Ca 2ϩ efflux and depletion of sarcoplasmic reticulum Ca 2ϩ stores before PAO treatment only modestly slowed the rate at which hypercontracture developed (see Fig. 5 ). On the other hand, CSA, which inhibits PAO-induced Ca 2ϩ efflux via PTP, slowed the rate of hypercontracture development more effectively (see Fig. 6 ). The delay rather than prevention of hypercontracture by CSA is probably related to the PAO-induced increased myofibrillar Ca 2ϩ sensitivity. Thus even if CSA was able to inhibit major part of PAO-induced mitochondrial Ca 2ϩ efflux, hypercontracture still developed slowly due to increased myofibrillar Ca 2ϩ sensitivity. The ability of DTT and NEM to inhibit both increased myofilament Ca 2ϩ sensitivity and PAO-induced MPT accounts for their complete effectiveness at preventing PAO-induced hypercontracture. An important finding is the rapidity (within seconds) with which DTT application reversed PAO-induced hypercontracture (Fig. 5A) . The most likely explanation for this rapid effect is that DTT reversed PAO-induced sulfhydryl group cross-linking, which we postulate was the cause of the increased myofibrillar Ca 2ϩ sensitivity (by an unknown mechanism). An alternative possibility is that increased myofibrillar Ca 2ϩ sensitivity was due to reduction in the local ATP-to-ADP ratio as a result of PAO-induced MPT, because a low ATP-to-ADP ratio favors strongly bound cross-bridge states, thereby sensitizing the myofilaments to Ca 2ϩ (19) . The rapid restoration of ⌬⌿ by DTT in isolated mitochondria after exposure to PAO (Fig. 7) could potentially restore a normal ATP-to-ADP ratio and reverse the increased myofibrillar Ca 2ϩ sensitivity. However, the nearly instantaneous relaxing effect of DTT on PAO-induced hypercontracture seems inconsistent with this mechanism, because in rat cardiomyocytes exposed to anoxia/ reoxygenation, mitochondrial ⌬⌿ recovery was fast, but ATP regeneration occurred slowly, taking Ͼ10 min to restore prehypoxic levels (8) . PAO also had no effect on actomyosin ATPase activity in vitro (Fig. 8C) , suggesting that increased Ca 2ϩ sensitivity was not related to enhanced ATP hydrolysis by this enzyme, generating reduced local ATP-to-ADP ratios in the vicinity of myofilaments. Thus, although the mechanism of the effect of PAO on myofibrillar Ca 2ϩ sensitivity remains unclear, it is most consistent with a direct effect on contractile elements of sulfhydryl group cross-linking. The specific protein targets of this agent, however, remain unknown, with respect to the subunits of the multiprotein PTP complex that must be cross-linked via vicinal sulfhydryl groups to induce MPT.
PAO, as a general sulfhydryl group cross-linking agent, is likely to affect a variety of cellular proteins. Although we cannot exclude the possibility that PAO affected other cellular processes that regulate cytoplasmic free Ca 2ϩ , mitochondrial Ca 2ϩ efflux coupled with increased myofilament Ca 2ϩ sensitivity provides a sufficient explanation for hypercontracture. In addition to inducing MPT, PAO has been shown to activate neutrophil NADPH oxidase (9) receptor-mediated endocytosis (32), cause tumor necrosis factor-dependent activation of nuclear factor-B (34), and stimulate 2-deoxyglucose transport (4) . None of these effects can explain the rapid onset of hypercontracture and irreversible cell injury. Furthermore, PAO has been shown to increase intracellular [Ca 2ϩ ] in endothelial cells in association with tyrosine phosphorylation of cytoskeletal proteins (11) . However, the potent tyrosine phosphatase inhibitor peroxyvanadate did not induce hypercontracture in cardiac myocytes.
Like PAO, FCCP induces mitochondrial Ca 2ϩ efflux and MPT in Ca 2ϩ -loaded mitochondria (3) but did not cause hypercontracture in isolated myocytes. FCCP by itself induced rigor (shortened square cells) rather than hypercontracture (rounded cells with extensive blebs), as has been reported previously (7) . In addition, pretreatment with FCCP prevented hypercontracture (but not MPT) by PAO. From Fig. 3, B and C 
PAO-Induced Membrane Injury and Cell Death
Hypercontracture did not directly cause irreversible membrane injury and cell death in this model, because BDM prevented hypercontracture yet did not prevent the latter (Fig. 10) . In contrast, preincubation with BAPTA-AM prevented both hypercontracture and membrane injury (Fig. 10) , implicating the MPT-induced increase in cytoplasmic Ca 2ϩ , rather than hypercontracture per se, as the primary cause of irreversible injury. It is not surprising that a nonmechanically mediated mode of necrotic cell death exists in cardiac tissue, because widespread MPT is known to promote necrotic cell death in noncontractile cells that are incapable of hypercontracture (24) . This nonmechanical mode may therefore represent a general necrotic cell death mechanism triggered by high cytoplasmic free Ca 2ϩ and low [ATP], both consequences of MPT (7).
Implications
Although no direct link can be established on the basis of our findings, the effects of PAO bear some striking similarities to reperfusion/reoxygenation injury, including MPT (5), hypercontracture, and enhanced susceptibility to hypercontracture (23), irreversible membrane injury, prevention of hypercontracture by pretreatment with metabolic inhibitors (13) , and partial protection by CSA (17) . However, there are also significant differences. In contrast to the normal state of mitochondrial Ca 2ϩ loading before PAO exposure, mitochondria become heavily Ca 2ϩ loaded during ischemia/anoxia (10), a key factor directly promoting MPT (5, 17) , hypercontracture, and irreversible injury on reoxygenation (16, 26) . Also, as discussed above, PAO is a potent sulfhydryl group cross-linker, which is likely to affect other proteins besides those affected by reperfusion/reoxygenation, and vice versa. Despite these differences, however, the similar effects on cardiac function are intriguing and potentially illuminating. Both hypercontracture (30) and MPT (5, 17) have been proposed to play central roles in reperfusion/ reoxygenation injury, but the relationship between the two, if any, has not been well documented. Our findings suggest that Ca 2ϩ release from mitochondria during MPT can markedly enhance hypercontracture, provided that myofibrillar Ca 2ϩ sensitivity is increased. In the setting of reperfusion/reoxygenation, in which mitochondria are highly Ca 2ϩ loaded (to a much greater extent than mitochondria in this study), mitochondrial Ca 2ϩ release during MPT is likely to make an even greater contribution to hypercontracture, with rapid generation of uncontrolled excessive force directly disrupting sarcolemmal membrane integrity and causing immediate enzyme release (30) . In addition, the rise in free cytoplasmic [Ca 2ϩ ] may trigger MPT-associated necrotic cell death independent of hypercontracture and associated with delayed enzyme release.
In conclusion, both of these MPT-related necrotic cell death mechanisms, in addition to apoptosis (17) , are likely to play important roles in reperfusion/reoxygenation injury in intact cardiac muscle. In view of its efficacy at rapidly inducing MPT and increasing myofibrilar Ca 2ϩ sensitivity, PAO may be a useful tool for investigating the underlying mechanisms. Our findings suggest that prevention of MPT during reperfusion/reoxygenation has promise as a therapeutic target.
